Skip to content
JCP
PCC
News
CME
About
Authors
Sign In
Subscribe
Search
Advanced Search
Menu
JCP
PCC
News
CME
About
Authors
Sign In
Subscribe
Clinical Topics
View All
Depression
Neurologic
Anxiety
Schizophrenia
Trauma
Psychopharmacology
Bipolar
Tardive Dyskinesia
OCD
Addiction
View All
Columns
View All
ASCP Corner
Clinical & Practical Psychopharmacology
Rounds General Hospital
Academic Highlights
Banner Alzheimer’s Institute
Focus on Geriatric Psychiatry
Patricia J. Schlicht, BSN,MA
JCP
Original Research
Benefits of Ashwagandha for Schizophrenia
July 10, 2018
Read a study on how a extract of Ashwagandha (Withania somnifera), when added to antipsychotic medications to patients with schizophrenia.
K. N. Roy Chengappa
,
Jaspreet S. Brar
,
Jessica M. Gannon
, et al
JCP
Original Research
Varenicline for Smoking Cessation in Bipolar Disorder: A Randomized, Double-Blind, Placebo-Controlled Study
June 10, 2014
K. N. Roy Chengappa
,
Kenneth A. Perkins
,
Jaspreet S. Brar
, et al
JCP
Original Research
Randomized Placebo-Controlled Adjunctive Study of an Extract of
Withania somnifera
for Cognitive Dysfunction in Bipolar Disorder
November 15, 2013
K. N. Roy Chengappa
,
Christopher R. Bowie
,
Patricia J. Schlicht
, et al